Coagulation, platelet activation and thrombosis in xenotransplantation

Current Opinion in Organ Transplantation

Volumn 15, Issue 2, 2010, Pages 212-218

  Schmelzle, Moritz ^a,b   Am Esch II, Jan Schulte ^b   Robson, Simon C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

CD39; Endothelial cell; Platelets; Thrombosis; Xenotransplantation

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOVIRUS VECTOR; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; CD39 ANTIGEN; CD4 ANTIGEN; CLOPIDOGREL; DESMOPRESSIN; ENDOTHELIAL PROTEIN C RECEPTOR; GLYCOPROTEIN VI; HEME OXYGENASE 1; LOW MOLECULAR WEIGHT HEPARIN; PROTEINASE ACTIVATED RECEPTOR; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; SEROTONIN; THROMBIN; THROMBOPLASTIN; THROMBOXANE A2; TISSUE FACTOR PATHWAY INHIBITOR; VON WILLEBRAND FACTOR; WARFARIN;

BLOOD CLOTTING; BLOOD CLOTTING DISORDER; DIABETES MELLITUS; DRUG TARGETING; ENDOTHELIUM CELL; GRAFT FAILURE; GRAFT OCCLUSION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HEPATOCYTE TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOINCOMPATIBILITY; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; KIDNEY TRANSPLANTATION; LIVER FAILURE; LUNG TRANSPLANTATION; MEMBRANE MICROPARTICLE; MESENCHYMAL STEM CELL; MICROENCAPSULATION; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PLATELET MICROPARTICLE; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; TRANSPLANTATION TOLERANCE; VIRAL GENE THERAPY; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTICOAGULANTS; BLOOD COAGULATION; ENDOTHELIUM, VASCULAR; FIBRINOLYTIC AGENTS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, HUMORAL; IMMUNOSUPPRESSION; PLATELET ACTIVATION; SPECIES SPECIFICITY; STEM CELL TRANSPLANTATION; SWINE; THROMBOSIS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 77952245682     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283373ccc     Document Type: Review

References (68)

1. Source: National Organ Procurement and Transplantation Network. http://optn. transplant.hrsa.gov/.
2. Furie B. Source: Scientific Registry of Transplant Recipients.
3. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008;359:938-949. An updated review of coagulation and thrombosis models in vivo, incorporating role of microparticles.
4. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357:2482-2494.
5. Banz Y, Beldi G, Wu Y, et al. CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation. Br J Haematol 2008;142:627-637. First documentation that the ectonucleotidase CD39 associates with circulating microparticles; wherein it directly (or indirectly) confers functional properties. (Pubitemid 352020213)
6. Lee KF, Salvaris EJ, Roussel JC, et al. Recombinant pig TFPI efficiently regulates human tissue factor pathways. Xenotransplantation 2008;15:191-197. Using expression systems in primate cells, the authors show no apparent incompatibilities between recombinant pig TFPI and the human TF pathway. The observed thromboregulatory failure of pig endothelium and associated aberrant TF activity in xenograft rejection might be associated with TFPI posttranslational modifications in pig cells or the loss from activated endothelial cells.
7. Roussel JC, Moran CJ, Salvaris EJ, et al. Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI. Am J Transplant 2008;8:1101-1112. Molecular studies and further confirmation that swine thrombomodulin is a poor cofactor for the activation of human protein C and TAFI; EGF5 appears to be the most important determinant of compatibility.
8. Robson SC, Wu Y, Sun X, et al. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb He-most 2005;31:217-233; Review. (Pubitemid 40605196)
9. Ezzelarab M, Garcia B, Azimzadeh A, et al. The innate immune response and activation of coagulation in alpha1, 3-galactosytransferase gene-knockout xenograft recipients. Transplantation 2009;87:805-812. A good evidence that xenograft rejection is associated with activation of the innate immune system and involves both porcine and primate cellular expression of TF.
10. Hisashi Y, Yamada K, Kuwaki K, et al. Rejection of cardiac xenografts transplanted from alpha1, 3-galactosytransferase gene-knockout (GalT-KO) pigs to baboons. Am J Transplant 2008;8:2516-2526. Despite the absence of the Gal epitope, acute and chronic antibody together with cell-mediated rejection and vasculopathy develops in cardiac xenografts.
11. Tseng YL, Kuwaki K, Dor FJ, et al. alpha1, 3-Galactosytransferase gene knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 2005;80:1493-1500. (Pubitemid 41803633)
12. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1, 3-galactosy transferase gene-knockout pigs as donors: initial experience. Nat Med 2005;11:29-31. (Pubitemid 40215833)
13. Chen G, Qian H, Starzl T, et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005;11:1295-1298. (Pubitemid 41752909)
14. Shimizu A, Hisashi Y, Kuwaki K, et al. Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1, 3-galactosyltrans-ferase gene-knockout pigs in baboons. Am J Pathol 2008;172:1471-1481. Slowly progressive humoral rejection and disordered thromboregulation remain obstacles to long-term xenograft survival. (Pubitemid 351793341)
15. Imai M, Takigami K, Guckelberger O, et al. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1) CD39 in xenograft rejection. Mol Med 1999;5:743-752. (Pubitemid 32937034)
16. Knosalla C, Yazawa K, Behdad A, et al. Renal and cardiac endothelial heterogeneity impact acute vascular rejection in pig-to-baboon xenotransplantation. Am J Transplant 2009;9:1006-1016. Vascular gene expression profiles differ in renal and cardiac xenografts, suggesting that therapeutic targets may differ in renal and cardiac xenotransplantation.
17. Shimizu A, Yamada K, Yamamoto S, et al. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts. J Am Soc Nephrol 2005;16:2732-2745.
18. Lin PY, Shen HC, Chen CJ, et al. The inhibition in tumor necrosis factor-alpha-induced attenuation in endothelial thrombomodulin expression bycarvedilol is mediated by nuclear factor-kappaB and reactive oxygen species. J Thromb Thrombolysis 2010;29:52-59.
19. Rees DA, Giles P, Lewis MD, Ham J. Adenosine regulates thrombomodulin and endothelial protein C receptor expression in folliculostellate cells of the pituitary gland. Purinergic Signal 2009. [Epub ahead of print] Data links purinergic and coagulation systems via adenosine and thrombomodulin.
20. Chen D, Riesbeck K, McVey JH, et al. Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins. Xenotransplantation 2001;8:258-265. (Pubitemid 33020984)
21. Kikuchi G, Yoshida T, Noguchi M. Heme oxygenase and heme degradation. Biochemical and biophysical research communications. Biochem Biophys Res Commun 2005;338:558-567.
22. Sato K, Balla J, Otterbein L, et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 2001;166:4185-4194. (Pubitemid 32224952)
23. Zhu M, Zhang W, Liu F, et al. Resistance to antixenogeneic response by combining alpha-Gal silencing with HO-1 upregulation. Transpl Immunol 2008;19:202-208.
24. Evans RJ, Austen DE. Assay and characterization of the factor in porcine and bovine plasma which aggregates human platelets. Br J Haematol 1977;36:117-126.
25. Pareti FI, Mazzucato M, Bottini E, Mannucci PM. Interaction of porcine von Willebrand factor with the platelet glycoproteins Ib and IIb/IIIa complex. Br J Haematol 1992;82:81-86.
26. Mazzucato M, De Marco L, Pradella P, et al. Porcine von Willebrand Factor binding to human platelet GPIb induces transmembrane calcium influx. Thromb Haemost 1996;75:655-660. (Pubitemid 26138270)
27. Schulte Am Esch J 2nd, Robson SC, Knoefel WT, et al. O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors. Xenotransplantation 2005;12:30-37.
28. Schulte am Esch J 2nd, Cruz MA, Siegel JB, et al. Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor. Blood 1997;90:4425-4437. (Pubitemid 27508448)
29. Kim YT, Lee HJ, Lee SW, et al. Pretreatment of porcine pulmonary xenograft with desmopressin: a novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex-vivo model of swine-to-human pulmonary xenotransplantation. Xenotransplantation 2008;15:27-35. Elegant approach to modulate von Willebrand factor expression in porcine xenografts.
30. Cantu E, Balsara KR, Li B, et al. Prolonged function of macrophage, von Willebrand factor-deficient porcine pulmonary xenografts. Am J Transplant 2007;7:66-75. (Pubitemid 44952857)
31. Lin CC, Chen D, McVey JH, et al. Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells. Transplantation 2008;86:702-709.
32. Kahner BN, Dorsam RT, Kunapuli SP. Role of P2Y receptor subtypes in platelet-derived microparticle generation. Front Biosci 2008;13:433-439.
33. Grewal PK, Uchiyama S, Ditto D, et al. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 2008;14:648-655. The hepatic Ashwell receptor is linked to vWF homeostasis and is shown to eliminate platelets desialylated by neuraminidase activity. (Pubitemid 351809544)
34. Rumjantseva V, Grewal PK, Wandall HH, et al. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med 2009;15:1273-1280.
35. Kopp CW, Siegel JB, Hancock WW, et al. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. Transplantation 1997;63:749-758. (Pubitemid 27132211)
36. Kopp CW, Robson SC, Siegel JB, et al. Regulation of monocyte tissue factor activity by allogeneic and xenogeneic endothelial cells. Thromb Haemost 1998;79:529-538.
37. Siegel JB, Grey ST, Lesnikoski BA, et al. Xenogeneic endothelial cells activate human prothrombin. Transplantation 1997;64:888-896. (Pubitemid 27422273)
38. Enjyoji K, Sevigny J, Lin Y, et al. Targeted disruption of cd39/ATP dipho-sphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 1999;5:1010-1017. (Pubitemid 29439571)
39. Imai M, Takigami K, Guckelberger O, et al. Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival. Transplantation 2000;70:864-870.
40. Buergler JM, Maliszewski CR, Broekman MJ, et al. Effects of SolCD39, a novel inhibitor of platelet aggregation, on platelet deposition and aggregation after PTCA in a porcine model. J Thromb Thrombolysis 2005;19:115-122.
41. Li SZ, Qu YC, Liu BQ, et al. Synergistic effects of alpha-1, 2-fucosyltransferase, DAF, and CD59 in suppression of xenogenic immunological responses. Xenotransplantation 2009;16:27-33.
42. Hara H, Long C, Lin YJ, et al. In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Transpl Int 2008;21:1163-1174.
43. Zhen-Wei X, Jian-LeS, Qi Q, et al. Hemeoxygenase-1 improves the survival of discordant cardiac xenograft through its anti-inflammatory and antiapoptotic effects. Pediatr Transplant 2007;11:850-859. (Pubitemid 350054846)
44. Schirmer JM, Fass DN, Byrne GW, et al. Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival. Xenotransplantation 2004;11:436-443.
45. Byrne GW, Davies WR, Oi K, et al. Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival. Transplantation 2006;82:1787-1791. (Pubitemid 46035668)
46. Byrne GW, Schirmer JM, Fass DN, et al. Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function. Am J Transplant 2005;5:1011-1020.
47. Cowan PJ, Aminian A, Barlow H, et al. Protective effects of recombinant human antithrombin III in pig-to-primate renal xenotransplantation. Am J Transplant 2002;2:520-525. (Pubitemid 36306870)
48. Chen Y, Tan W, Qin S, et al. Cloning of the full-length cDNA of porcine antithrombin III and comparison with its human homolog. Comp Med 2009;59:372-377.
49. Cozzi E, Simioni P, Boldrin M, et al. Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts. Transplantation 2005;80:1501-1510. (Pubitemid 41803634)
50. Henriksson HB, Svanvik T, Jonsson M, et al. Transplantation of human mesenchymal stems cells into intervertebral discs in a xenogeneic porcine model. Spine (Phila PA 1976) 2009;34:141-148.
51. Schulte am Esch JS 2nd, Knoefel WT, Klein M, et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005;23:463-470. (Pubitemid 40478484)
52. Rossignol J, BoyerC, Thinard R, et al. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J Cell Mol Med 2009. [Epub ahead of print]
53. González MA, Gonzalez-Rey E, Rico L, et al. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 2009;60:1006-1019.
54. Habiro K, Sykes M, Yang JG. Induction of human T-Cell tolerance to pig xenoantigens via thymus transplantation in mice with an established human immune system. Am J Transplant 2009;9:1324-1329.
55. Lan P, Tonomura N, Shimizu A, et al. Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood 2006;108:487-492. (Pubitemid 44061346)
56. Tonomura N, Habiro K, Shimizu A, et al. Antigen specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. Blood 2008;111:4293-4296. State of art approach to expressing humanized immune system in mouse to study mechanisms of xenograft rejection.
57. Tonomura N, Shimizu A, Wang S, et al. Pig islet xenograft rejection in a mouse model with an established human immune system. Xenotransplantation 2008;15:129-135. (Pubitemid 351601117)
58. Vu DM, Masuda H, Yokoyama TA, et al. CD133+ endothelial progenitor cells as a potential cell source for a bioartificial glomerulus. Tissue Eng Part A 2009;15:3173-3182.
59. Hashi CK, Zhu Y, Yang GY, et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci USA 2007;104:11915-11920. (Pubitemid 47185605)
60. Smadja DM, Basire A, Amelot A, et al. Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells. J Cell Mol Med 2008;12:975-986. (Pubitemid 351718075)
61. Wu BJ, Midwinter RG, Cassano C, et al. Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2009;29:1537-1542.
62. Sambuceti G, Morbelli S, Vanella L, et al. Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectin. Stem Cells 2009;27:399-407.
63. Tarzami ST, Wang G, Li W, et al. Thrombin and PAR-1 stimulate differentiation of bone marrow-derived endothelial progenitor cells. J Thromb Haemost 2006;4:656-663.
64. Cui H, Tucker-Burden C, Cauffiel SM, et al. Long-term metabolic control of autoimmune diabetes in spontaneously diabetic nonobese diabetic mice by nonvascularized microencapsulated adult porcine islets. Transplantation 2009;88:160-169. Progress in microencapsulation.
65. Mei J, Sgroi A, Mai G, et al. Improved survival of fulminant liver failure by transplantation of microencapsulated cryopreserved porcine hepatocytes in mice. Cell Transplant 2009;18:101-110.
66. Cai WW, Gu YJ, Wang XN, Chen CZ. Heparin coating of small-caliber decellularized xenografts reduces macrophage infiltration and intimal hyperplasia. Artif Organs 2009;33:448-455.
67. Murua A, Orive G, Hernandez RM, Pedraz JL. Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression. J Control Release 2009;137:174-178. Progress in microencapsulation.
68. Howard MA, Coghlan M, David R, Pfueller SL. Coagulation activities of plasma microparticles. Thromb Res 1988;50:145-156.